Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other 1Classical hematology 1

Conditions

Neoplasms 68Venous Thromboembolism 60Anemia 33Leukemia, Myeloid, Acute 28Anemia, Sickle Cell 26Multiple Myeloma 25Hematologic Neoplasms 25Myelodysplastic Syndromes 24Febrile Neutropenia 24Leukemia 22Lymphoma 19Anemia, Aplastic 19Thrombocytopenia 17Myeloproliferative Disorders 16Breast Neoplasms 16Anemia, Refractory, with Excess of Blasts 16Neutropenia 14Venous Thrombosis 13Lymphoma, Non-Hodgkin 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms, Plasma Cell 12Lung Neoplasms 12Hodgkin Disease 12Fanconi Anemia 12Colorectal Neoplasms 12Ovarian Neoplasms 11Leukemia, Lymphocytic, Chronic, B-Cell 10Thrombosis 9Pulmonary Embolism 9Pancreatic Neoplasms 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Gangliosidosis, GM1 × Classical hematology × Clear all
NCT06539169 2024-11-14

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

xCures

Recruiting
1,000 enrolled
Classical hematologyOtherPlasma cell

Alzheimer Disease, Amyloidosis, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Cystic Fibrosis, Ehlers-Danlos Syndrome, Gaucher Disease, Glycogen Storage Disease Type II, Huntington Disease, Myasthenia Gravis, Gangliosidosis, GM1, alpha-Thalassemia, beta-Thalassemia, Muscular Dystrophy, Duchenne, Insomnia, Fatal Familial, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡